Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics and Interaction of Gabapentin and Oxycodone
NCT04315181Phase 1Completed
- Start
- Mar 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gabapentin and oxycodone in opioid use disorder (OUD) and sedative use disorder (SUD). Started Mar 2019; status: completed.
02
Drugs
gabapentinoxycodone
03
Conditions
opioid use disorder (OUD)sedative use disorder (SUD)
Beyond the preview
Go deeper on NCT04315181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315181.